251 related articles for article (PubMed ID: 12203741)
1. A POMS short form for cancer patients: psychometric and structural evaluation.
Baker F; Denniston M; Zabora J; Polland A; Dudley WN
Psychooncology; 2002; 11(4):273-81. PubMed ID: 12203741
[TBL] [Abstract][Full Text] [Related]
2. [The psychometric properties of the Spanish version of the stroke-adapted 30-item Sickness Impact Profile (SIP30-AI)].
Carod-Artal FJ; González-Gutiérrez JL; Egido-Herrero JA; Varela de Seijas E
Rev Neurol; 2007 Dec 1-15; 45(11):647-54. PubMed ID: 18050095
[TBL] [Abstract][Full Text] [Related]
3. [The German short version of "Profile of Mood States" (POMS): psychometric evaluation in a representative sample].
Albani C; Blaser G; Geyer M; Schmutzer G; Brähler E; Bailer H; Grulke N
Psychother Psychosom Med Psychol; 2005 Jul; 55(7):324-30. PubMed ID: 15986282
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and cultural adaptation of a German version of the AIMS2-SF questionnaire (German AIMS2-SF).
Rosemann T; Körner T; Wensing M; Schneider A; Szecsenyi J
Rheumatology (Oxford); 2005 Sep; 44(9):1190-5. PubMed ID: 15972355
[TBL] [Abstract][Full Text] [Related]
5. Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.
Carleton RN; Collimore KC; Asmundson GJ
J Anxiety Disord; 2007; 21(1):131-41. PubMed ID: 16675196
[TBL] [Abstract][Full Text] [Related]
6. Psychometric validation of the French version of the quality of life in epilepsy inventory (QOLIE-31): comparison with a generic health-related quality of life questionnaire.
Picot MC; Crespel A; Daurès JP; Baldy-Moulinier M; El Hasnaoui A
Epileptic Disord; 2004 Dec; 6(4):275-85. PubMed ID: 15634625
[TBL] [Abstract][Full Text] [Related]
7. Standardization of the Korean version of Mini-Mental Adjustment to Cancer (K-Mini-MAC) scale: factor structure, reliability and validity.
Kang JI; Chung HC; Kim SJ; Choi HJ; Ahn JB; Jeung HC; Namkoong K
Psychooncology; 2008 Jun; 17(6):592-7. PubMed ID: 17957732
[TBL] [Abstract][Full Text] [Related]
8. [Pain coping strategies: French adaptation of the coping strategies questionnaire (CSQ-F)].
Irachabal S; Koleck M; Rascle N; Bruchon-Schweitzer M
Encephale; 2008 Jan; 34(1):47-53. PubMed ID: 18514150
[TBL] [Abstract][Full Text] [Related]
9. [Factorial analysis and internal consistency of the French version of the Toronto Alexithymia Scale (TAS 20), in obese women].
Pinaquy S; Chabrol H; Barbe P
Encephale; 2002; 28(4):277-82. PubMed ID: 12232536
[TBL] [Abstract][Full Text] [Related]
10. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
[TBL] [Abstract][Full Text] [Related]
11. [Disease-specific Questionnaire for Quality of Life in Patients with Peripheral Arterial Occlusive Disease in the Stage of Critical Ischemia (FLeQKI)--methodical development of a specific measuring instrument and psychometric evaluation of its validity and reliability (Part 1)].
Wohlgemuth WA; Olbricht W; Klarmann S; Engelhardt M; Freitag MH; Wölfle K; Bohndorf K; Kirchhof K
Rofo; 2007 Dec; 179(12):1251-7. PubMed ID: 18004695
[TBL] [Abstract][Full Text] [Related]
12. Screening for distress can predict loss of follow-up and treatment in cancer patients: results of development and validation of the Distress Inventory for Cancer Version 2.
Thomas BC; Thomas I; Nandamohan V; Nair MK; Pandey M
Psychooncology; 2009 May; 18(5):524-33. PubMed ID: 18792076
[TBL] [Abstract][Full Text] [Related]
13. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale.
McQuellon RP; Russell GB; Cella DF; Craven BL; Brady M; Bonomi A; Hurd DD
Bone Marrow Transplant; 1997 Feb; 19(4):357-68. PubMed ID: 9051246
[TBL] [Abstract][Full Text] [Related]
14. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament.
Akiskal HS; Mendlowicz MV; Jean-Louis G; Rapaport MH; Kelsoe JR; Gillin JC; Smith TL
J Affect Disord; 2005 Mar; 85(1-2):45-52. PubMed ID: 15780675
[TBL] [Abstract][Full Text] [Related]
15. Psychometric properties of the Czech version of the Quality of Life in Epilepsy Inventory (QOLIE-31).
Tlusta E; Kubena A; Salek S; Vlcek J
Epilepsy Behav; 2007 May; 10(3):407-11. PubMed ID: 17317324
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ).
Nicolucci A; Giorgino R; Cucinotta D; Zoppini G; Muggeo M; Squatrito S; Corsi A; Lostia S; Pappalardo L; Benaduce E; Girelli A; Galeone F; Maldonato A; Perriello G; Pata P; Marra G; Coronel GA
Diabetes Nutr Metab; 2004 Aug; 17(4):235-43. PubMed ID: 15575345
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of an Asthma-Specific Quality of Life (A-QOL) questionnaire.
Lee EH; Kim SH; Choi JH; Jee YK; Nahm DH; Park HS
J Asthma; 2009 Sep; 46(7):716-21. PubMed ID: 19728212
[TBL] [Abstract][Full Text] [Related]
18. Health related quality of life in stem cell transplantation: clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19).
Andersson I; Hjermstad M; Stockelberg D; Persson LO
Acta Oncol; 2008; 47(2):275-85. PubMed ID: 18210301
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ).
Wardenaar KJ; van Veen T; Giltay EJ; de Beurs E; Penninx BW; Zitman FG
Psychiatry Res; 2010 Aug; 179(1):101-6. PubMed ID: 20472297
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of lifetime mood and panic-agoraphobic spectrum symptoms on quality of life of patients with rheumatoid arthritis.
Piccinni A; Maser JD; Bazzichi L; Rucci P; Vivarelli L; Del Debbio A; Catena M; Bombardieri S; Dell'Osso L
Compr Psychiatry; 2006; 47(3):201-8. PubMed ID: 16635649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
